Does Selexipag Interact with Rifampin?
Selexipag and Rifampin have a moderate drug interaction according to U.S. FDA drug labeling data. CYP2C8 inducer that halved active metabolite exposure. Increase selexipag dose up to twice when co-administered; reduce when rifampin is stopped. The mechanism involves cyp2c8 and ugt1a3/2b7 induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Selexipag Class
- Prostacyclin Receptor Agonist
- Rifampin Class
- Rifamycin Antibacterial
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Selexipag and Rifampin occurs because cyp2c8 and ugt1a3/2b7 induction. Clinically, this means cyp2c8 inducer that halved active metabolite exposure. increase selexipag dose up to twice when co-administered; reduce when rifampin is stopped. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Selexipag and your doctor is considering prescribing Rifampin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider